Total Valuation
BioCardia has a market cap or net worth of €11.93M. The enterprise value is €4.96M.
Market Cap€11.93M
Enterprise Value€4.96M
Share Statistics
BioCardia has 14,884,328 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,884,328
Owned by Insiders14.61%
Owned by Institutions<0.01%
Financial Efficiency
BioCardia’s return on equity (ROE) is -9.19 and return on invested capital (ROIC) is -581.73%.
Return on Equity (ROE)-9.19
Return on Assets (ROA)-2.41
Return on Invested Capital (ROIC)-581.73%
Return on Capital Employed (ROCE)-8.44
Revenue Per Employee0.00
Profits Per Employee-484.00K
Employee Count17
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioCardia is ―. BioCardia’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio9.31
Price to Fair Value9.31
Price to FCF-1.12
Price to Operating Cash Flow-1.32
PEG Ratio0.02
Income Statement
In the last 12 months, BioCardia had revenue of 0.00 and earned -8.23M in profits. Earnings per share was -1.23.
Revenue0.00
Gross Profit-505.00K
Operating Income-8.28M
Pretax Income-8.23M
Net Income-8.23M
EBITDA-7.72M
Earnings Per Share (EPS)-1.23
Cash Flow
In the last 12 months, operating cash flow was -7.48M and capital expenditures -10.00K, giving a free cash flow of -7.49M billion.
Operating Cash Flow-7.48M
Free Cash Flow-7.49M
Free Cash Flow per Share-0.50
Dividends & Yields
BioCardia pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change0.00%
50-Day Moving Average0.28
200-Day Moving Average0.28
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
BioCardia upcoming earnings date is Aug 12, 2026, After Close (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
BioCardia as a current ratio of 1.12, with Debt / Equity ratio of -38.65%
Current Ratio1.12
Quick Ratio1.12
Debt to Market Cap0.00
Net Debt to EBITDA0.25
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioCardia has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioCardia EV to EBITDA ratio is -0.82, with an EV/FCF ratio of -0.86.
EV to Sales0.00
EV to EBITDA-0.82
EV to Free Cash Flow-0.86
EV to Operating Cash Flow-0.86
Balance Sheet
BioCardia has €951.00K in cash and marketable securities with €412.00K in debt, giving a net cash position of €539.00K billion.
Cash & Marketable Securities€951.00K
Total Debt€412.00K
Net Cash€539.00K
Net Cash Per Share€0.04
Tangible Book Value Per Share€0.13
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioCardia is €13.56, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€13.56
Price Target Upside4743.36% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―